Eris Lifesciences Limited (NSE: ERIS)

Eris Lifesciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	24,853	19,913	16,618	13,262	11,926	10,582
Revenue Growth (YoY)	40.02%	19.83%	25.31%	11.20%	12.71%	9.41%
Cost of Revenue	5,902	3,964	3,613	2,640	2,419	1,753
Gross Profit	18,951	15,949	13,005	10,621	9,507	8,829
Selling, General & Admin	4,768	4,212	3,548	2,622	2,439	2,317
Other Operating Expenses	5,772	4,963	4,070	3,108	2,762	2,791
Operating Expenses	13,105	11,006	8,789	6,376	5,631	5,611
Operating Income	5,846	4,944	4,217	4,245	3,876	3,219
Interest Expense	-1,710	-848.01	-261.68	-41.46	-18.02	-21.62
Interest & Investment Income	70.1	70.1	22.99	60.98	22.85	16.09
Currency Exchange Gain (Loss)	18.56	18.56	-	-	-	-
Other Non Operating Income (Expenses)	72.73	55.73	17.22	15.19	14.46	51.65
EBT Excluding Unusual Items	4,297	4,240	3,995	4,280	3,895	3,265
Gain (Loss) on Sale of Investments	93.76	93.76	71.32	166.09	49.77	86.22
Gain (Loss) on Sale of Assets	-21.41	-21.41	-20.05	-42.54	-0.18	-37.36
Other Unusual Items	-	-	-	18.68	-	-
Pretax Income	4,369	4,312	4,046	4,422	3,945	3,314
Income Tax Expense	700.85	341.85	304.83	364.09	393.62	348.43
Earnings From Continuing Operations	3,669	3,971	3,742	4,058	3,551	2,965
Minority Interest in Earnings	-183.91	-50.71	79.98	3.24	-	-0.1
Net Income	3,485	3,920	3,822	4,061	3,551	2,965
Net Income to Common	3,485	3,920	3,822	4,061	3,551	2,965
Net Income Growth	-9.62%	2.57%	-5.90%	14.35%	19.78%	1.96%
Shares Outstanding (Basic)	136	136	136	136	136	137
Shares Outstanding (Diluted)	136	136	136	136	136	137
Shares Change (YoY)	0.02%	-	0.19%	0.02%	-1.03%	-0.25%
EPS (Basic)	25.61	28.82	28.10	29.89	26.16	21.61
EPS (Diluted)	25.58	28.79	28.07	29.88	26.14	21.59
EPS Growth	-9.65%	2.57%	-6.06%	14.31%	21.07%	2.18%
Free Cash Flow	5,931	3,568	-5,497	2,572	3,496	1,199
Free Cash Flow Per Share	43.54	26.21	-40.37	18.93	25.73	8.73
Dividend Per Share	-	-	7.350	6.010	5.500	2.870
Dividend Growth	-	-	22.30%	9.27%	91.64%	-
Gross Margin	76.25%	80.10%	78.26%	80.09%	79.71%	83.44%
Operating Margin	23.52%	24.83%	25.37%	32.01%	32.50%	30.42%
Profit Margin	14.02%	19.68%	23.00%	30.62%	29.78%	28.02%
Free Cash Flow Margin	23.87%	17.92%	-33.08%	19.40%	29.31%	11.33%
EBITDA	8,262	6,625	5,259	4,827	4,261	3,582
EBITDA Margin	33.24%	33.27%	31.65%	36.40%	35.73%	33.85%
D&A For EBITDA	2,416	1,682	1,043	582.18	384.9	363.22
EBIT	5,846	4,944	4,217	4,245	3,876	3,219
EBIT Margin	23.52%	24.83%	25.37%	32.01%	32.50%	30.42%
Effective Tax Rate	16.04%	7.93%	7.53%	8.23%	9.98%	10.52%
Revenue as Reported	25,236	20,330	16,963	13,731	12,206	10,895
Advertising Expenses	-	141.98	63.85	87.47	125.05	182.38

Source: S&P Capital IQ. Standard template. Financial Sources.